Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Olmesartan impurity 1 serves as a structural impurity related to the antihypertensive agent Olmesartan. This compound is essential for the analytical characterization of Olmesartan, particularly in the context of quality control and regulatory compliance in pharmaceutical development. Its presence and quantification can provide insights into the synthesis purity and stability profiles of Olmesartan formulations. -
Drug Impurity
Rivaroxaban impurity 67 is a defined impurity of the anticoagulant Rivaroxaban. This compound serves as a critical reference standard for analytical and quality control processes in the pharmaceutical industry. It aids in routine testing, stability analysis, and ensuring the purity of Rivaroxaban formulations in drug development and regulatory compliance. -
Drug Impurity
Cabozantinib impurity 7 is a synthetic impurity derivative of the tyrosine kinase inhibitor Cabozantinib. It serves as a crucial reference standard for quality control and analytical studies related to Cabozantinib production. This compound aids in the characterization and assessment of drug purity, essential for pharmacokinetics and toxicological research applications. -
Drug Impurity
Estradiol impurity 1 is a known impurity associated with the synthesis of Estradiol. This compound can serve as a critical reference for assessing the purity of Estradiol formulations in research and quality control applications. It is important for researchers studying the metabolism and pharmacokinetics of estrogenic compounds, as well as in the evaluation of drug safety and efficacy. -
Drug Intermediate
(1R,3S)-3-Hydroxycyclopentane carboxylic acid methyl ester serves as a valuable synthetic intermediate in pharmaceutical synthesis. This compound can facilitate the development of bioactive molecules and various drug formulations. Its unique structure aids in the exploration of novel therapeutic agents, making it an essential reagent for research in medicinal chemistry. -
Drug Impurity
Lifitegrast impurity 4 hydrochloride is a chemical impurity associated with Lifitegrast, primarily known for its role as a lymphocyte function-associated antigen-1 (LFA-1) antagonist. This impurity serves as a reference standard for analytical characterization and quality control in pharmacological studies of Lifitegrast. Research applications include assessing the purity of the active pharmaceutical ingredient and evaluating potential effects on drug efficacy and safety profiles. -
Drug Impurity
Sitagliptin impurity 25 is a known impurity associated with the DPP-4 inhibitor Sitagliptin, primarily targeting the Dipeptidyl Peptidase-4 enzyme. This compound is essential for quality control in the synthesis and analysis of Sitagliptin and is relevant for pharmacokinetic and toxicological studies. Its characterization supports research into drug formulation and regulatory compliance. -
Drug Impurity
Tamsulosin Impurity 6 serves as a drug impurity associated with the pharmaceutical compound tamsulosin. Its presence is critical for quality control and regulatory compliance during the manufacturing process. This compound is utilized in research applications to investigate the safety and efficacy of tamsulosin formulations, contributing to the understanding of potential impacts on drug performance and stability. -
Drug Impurity
Donepezil impurity 10 is a known impurity associated with the compound Donepezil, a reversible inhibitor of the enzyme acetylcholinesterase. This reagent is significant for analytical studies aimed at monitoring the purity of Donepezil in pharmaceutical formulations. It serves as a reference standard in quality control processes and method development, ensuring compliance with regulatory guidelines in drug manufacturing and research applications. -
Drug Impurity
Apixaban 4,5-dehydro carboxylic acid is a known drug impurity of Apixaban, an anticoagulant that functions primarily by inhibiting Factor Xa in the coagulation cascade. This compound serves as an important reference standard for analytical and stability studies in pharmaceutical development. Research applications include the assessment of drug purity, identification of degradation products, and evaluation of manufacturing processes. -
Drug Impurity
Tamsulosin impurity 21 is a chemical impurity associated with the drug Tamsulosin, which primarily targets the α1-adrenergic receptors. This impurity may serve as a valuable reference standard in the analysis of Tamsulosin formulations. Its identification is crucial for assessing the purity and quality of pharmaceutical products in drug development and quality control. -
Drug Impurity
Ramipril impurity 3 is a minor impurity associated with the angiotensin-converting enzyme (ACE) inhibitor Ramipril. This compound serves as a reference standard in the analysis of Ramipril for quality control and pharmaceutical research applications. Investigating impurities like Ramipril impurity 3 is essential for understanding the compound's safety profile and ensuring compliance with regulatory standards. -
Drug Impurity
Terbinafine impurity 13 is a known impurity associated with the antifungal agent Terbinafine. This compound serves as a reference standard for analytical studies and quality control in pharmaceutical formulations. Its characterization and quantification are essential for ensuring the purity and efficacy of Terbinafine in drug development and regulatory processes. -
Drug Impurity
Vildagliptin impurity 24 is a chemical impurity associated with the antidiabetic agent Vildagliptin. This impurity is crucial for analytical and quality control applications in pharmaceutical research and development. Its identification and quantification are essential for assessing the purity of Vildagliptin and ensuring the safety and efficacy of formulations containing this compound. -
Drug Impurity
Telmisartan impurity 5 (2-Boc-4'-(bromomethyl)biphenyl) is a characterized impurity associated with Telmisartan, an antihypertensive agent. It serves as a reference standard for quality control and analytical testing in pharmaceutical development. The presence and quantification of this impurity are crucial for assessing the purity and safety profiles of Telmisartan formulations. -
Drug Impurity
Escitalopram impurity 7 oxalate, also known as 3-Hydroxy citalopram oxalate, is a drug impurity associated with Escitalopram oxalate. This compound is utilized in pharmaceutical research and development to assess the purity and stability of escitalopram formulations. Its analysis is critical for ensuring compliance with regulatory standards and understanding the pharmacokinetic profile of the parent drug. -
Drug Impurity
Sitagliptin impurity 1 is a known impurity associated with the drug Sitagliptin, an inhibitor of the Dipeptidyl Peptidase-4 (DPP-4) enzyme. This compound is utilized primarily for quality control and analytical purposes in pharmaceutical research, ensuring the purity and safety of Sitagliptin formulations. It plays a critical role in the development and validation of quality assurance protocols in drug manufacturing. -
Drug Impurity
Montelukast impurity 14 is a chemical compound associated with the synthesis of Montelukast, specifically categorized as a drug impurity. This impurity can be used in analytical chemistry to assess the purity of Montelukast formulations and contribute to quality control processes. Its detection and quantification are essential for ensuring compliance with regulatory standards in pharmaceutical development and manufacturing. -
Drug Impurity
Terbinafine impurity 5 is a chemical impurity associated with the antifungal agent Terbinafine. It is primarily utilized in the analysis of drug formulations and quality control assessments to ensure the purity of pharmaceutical products. This impurity serves as an essential reference standard in stability testing and the development of analytical methods in pharmaceutical research. -
Drug Impurity
Sertraline impurity 5 is a chemical impurity associated with the selective serotonin reuptake inhibitor (SSRI) Sertraline. This compound is utilized primarily in pharmaceutical research for the assessment of drug purity and stability. It serves as a critical reference standard in the analytical evaluation of Sertraline formulations, helping to ensure compliance with regulatory quality standards in drug development. -
Drug Impurity
Cinacalcet impurity 4 is a chemical impurity associated with the drug Cinacalcet, which acts as a calcium-sensing receptor agonist. This impurity is relevant for analytical and quality control studies in pharmaceutical development related to Cinacalcet. Its identification and characterization are crucial for ensuring the purity and safety of therapeutic formulations. -
Drug Intermediate
3-Pyrimidin-2-yl-2-pyrimidin-2-ylmethyl-propionic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a crucial building block in the development of various therapeutic agents, facilitating the formation of complex structures for drug discovery. Its applications extend to medicinal chemistry, where it aids in the preparation of bioactive molecules targeting diverse biological pathways. -
Drug Impurity
Quetiapine impurity 10 is a chemical impurity associated with Quetiapine, an atypical antipsychotic. This compound serves as an essential reference standard for the identification and quantification of impurities in pharmaceutical formulations. Its analysis is critical for ensuring the purity and safety of Quetiapine in clinical and research applications. -
Drug Impurity
Methotrexate impurity 5, also known as Methotrexate α-Methyl Ester, is a chemical impurity associated with Methotrexate. This compound may serve as a valuable reference standard for quality control and analytical applications in pharmaceutical research. It aids in the evaluation of the purity and stability of Methotrexate formulations, contributing to the understanding of drug behavior and effectiveness. -
Drug Impurity
Bupropion impurity 18 is a characterized impurity of the antidepressant Bupropion. This compound serves as an important reference standard for analytical methods and quality control in pharmaceutical research. Its presence can influence the pharmacokinetic and pharmacodynamic properties of the parent drug, making it critical for studies evaluating drug safety and efficacy. Bupropion impurity 18 is essential for ensuring the integrity of Bupropion formulations in regulatory assessments. -
Drug Impurity
Acetazolamide impurity 5 is a chemical impurity associated with the drug Acetazolamide, which acts as a carbonic anhydrase inhibitor. This compound is primarily utilized in pharmaceutical research to assess the purity of Acetazolamide formulations and to study its potential effects in drug development. Understanding such impurities is critical for evaluating drug safety, efficacy, and regulatory compliance. -
Drug Impurity
Itraconazole impurity 10, also known as trans-Itraconazole, is a drug impurity associated with the antifungal agent Itraconazole. This compound serves as a valuable reference standard for analytical applications, including pharmacokinetic studies and quality control testing. Its characterization aids in understanding the stability and degradation pathways of Itraconazole in pharmaceutical formulations. Researchers can utilize this impurity to ensure compliance with regulatory standards in drug development. -
Drug Impurity
Testosterone impurity 28 is a defined impurity associated with testosterone. It serves as an important reference standard for the analysis and quality control of testosterone formulations. This impurity can be utilized in various research applications, including pharmacokinetics and toxicology studies, to ensure the integrity and safety of testosterone-related products. -
Drug Impurity
Budesonide impurity 84, also known as Di-Norbudesonide (mixture of diastereomers), serves as a relevant drug impurity in the characterization of Budesonide. This compound is utilized in pharmaceutical research for the investigation of drug stability, efficacy, and safety profiles. Its analysis is crucial for the development and quality control of corticosteroid formulations, ensuring compliance with regulatory standards. -
Drug Impurity
Levofloxacin impurity 10 is a drug impurity associated with the antibiotic levofloxacin. It serves as a key reference standard for analytical testing and quality control in pharmaceutical formulations. This compound plays a critical role in the assessment of drug purity and stability, aiding researchers in ensuring compliance with regulatory standards during drug development processes. -
Drug Impurity
Salmeterol impurity 10 is a known impurity of the long-acting β2 adrenergic agonist Salmeterol. This compound serves as a reference standard for analytical methods and is crucial for the quality control of pharmaceutical formulations containing Salmeterol. Its characterization is essential for ensuring the purity and efficacy of respiratory medications, particularly in the treatment of asthma and chronic obstructive pulmonary disease (COPD). -
Drug Impurity
Trazodone Impurity 3 Hydrochloride is a known impurity of Trazodone Hydrochloride. This compound serves as a critical reference standard for the identification and quantification of impurities in pharmaceutical formulations. It is primarily utilized in quality control and analytical studies to ensure compliance with regulatory guidelines in drug manufacturing. -
Drug Impurity
Gabapentin acid impurity 3 is a chemical impurity associated with the synthesis of Gabapentin acid. This compound is primarily used for quality control and analytical purposes in the pharmaceutical industry. Its presence and quantification are critical for assessing the purity of Gabapentin acid in drug formulations. -
Drug Impurity
Levothyroxine impurity 3 is a known impurity associated with Levothyroxine, a synthetic thyroid hormone. This compound is essential for research focused on the characterization of drug impurities, stability studies, and quality control of pharmaceutical formulations. It aids in understanding the impact of impurities on the efficacy and safety of thyroid medications. -
Losartan Impurity
Losartan Impurity 15 is a chemical entity related to Losartan, specifically characterized by the presence of an azido group. This impurity serves as an important analytical reference for the characterization and quality assessment of Losartan synthesis. It is commonly utilized in pharmaceutical research to study the stability and degradation pathways of Losartan, as well as to ensure compliance with regulatory standards for drug purity. -
Drug Impurity
Afatinib impurity 58 is a chemical reagent that serves as an impurity associated with the drug Afatinib. This compound may be utilized in analytical chemistry for quality control and stability studies of Afatinib formulations. Its presence is critical for ensuring the purity and safety of pharmaceutical products during research and development. -
Drug Impurity
Tenofovir impurity 20 is a chemical impurity associated with Tenofovir, an antiretroviral medication utilized in the treatment and prevention of HIV. This impurity is relevant for quality control and regulatory compliance in pharmaceutical research and development. It aids in the assessment of Tenofovir's purity and can be used in stability studies to ensure the integrity of therapeutic formulations. -
Drug Impurity
Clobazam impurity 1 is a characterized impurity associated with the anxiolytic agent Clobazam. This compound is essential for analytical purposes in quality control and method development for Clobazam formulations. Its presence and quantification can aid in assessing the purity and safety of pharmaceutical products containing Clobazam. -
Drug Impurity
Beclometasone dipropionate impurity 10 is a chemical impurity associated with the corticosteroid Beclometasone dipropionate. This impurity is relevant for drug quality assessments and stability studies in pharmaceutical research. It plays a critical role in ensuring the safety, efficacy, and regulatory compliance of corticosteroid formulations. Researchers can utilize this compound in purity testing and characterization of Beclometasone dipropionate. -
Drug Impurity
Prednisolone Impurity 6 is an identified impurity of the corticosteroid prednisolone. This compound is essential for understanding the purity profiles and characterization of prednisolone in pharmaceutical applications. It aids researchers in assessing the potential impacts of impurities on drug efficacy and safety, supporting quality control and compliance in drug development processes. -
Drug Intermediate
D-Pyroaspartic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its unique structure allows it to participate in the formation of various bioactive compounds, making it instrumental in the development of novel therapeutic agents. This compound serves as a valuable building block in chemical research and drug discovery applications. -
Drug Impurity
Ibrutinib Impurity 1 is a chemical impurity associated with the pharmacological compound Ibrutinib, an inhibitor of Bruton's tyrosine kinase (BTK). This impurity is relevant for analytical chemistry and quality control applications in pharmaceutical development to ensure the purity and safety of Ibrutinib formulations. It serves as an important reference standard for assessing the effects and stability of drug formulations containing Ibrutinib. -
Drug Impurity
Famotidine impurity 3 is a known impurity associated with Famotidine. It serves as a critical analytical standard for assessing the purity and quality of Famotidine formulations. This compound is essential for regulatory compliance and quality control in pharmaceutical research and development, particularly in studies examining drug stability and degradation profiles. -
Drug Impurity
Telmisartan impurity 13 is a chemical impurity associated with the antihypertensive agent Telmisartan. This compound can be utilized in quality control measures and analytical studies for drug formulation, ensuring the purity and efficacy of Telmisartan in pharmacological applications. Its characterization is crucial for compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Tamsulosin impurity 18 is a known impurity of the selective alpha-1 adrenergic antagonist, Tamsulosin, primarily utilized in the treatment of benign prostatic hyperplasia. This impurity is essential for quality control and analytical studies in pharmaceutical development, aiding in the assessment of Tamsulosin's purity and stability. Researchers can employ Tamsulosin impurity 18 for method validation, impurity profiling, and ensuring compliance with regulatory standards. -
Drug Intermediate
N-Fmoc-ethylenediamine hydrobromide is a crucial reagent for organic synthesis, primarily serving as a protective group for amino functionalities. This compound enhances the efficiency and selectivity of peptide and amino compound synthesis in biochemical research. Its properties make it an essential building block in various chemical reactions, facilitating the preparation of complex molecular structures. -
Drug Impurity
Adapalene impurity 1 is a known impurity associated with the topical retinoid Adapalene, primarily utilized for its role in dermatological treatments. Its presence necessitates monitoring during pharmaceutical formulation development to ensure product quality and efficacy. This reagent is integral for analytical studies focused on the characterization and quantification of drug impurities in pharmaceutical research. -
Drug Impurity
Duloxetine impurity 7 is a characterized impurity related to the pharmaceutical agent Duloxetine, which acts as a selective serotonin and norepinephrine reuptake inhibitor (SSNRI). This impurity is relevant for analytical chemistry and quality control in the production of Duloxetine, supporting the evaluation of purity and compliance with regulatory standards. Its study can provide insights into the synthesis and metabolic pathways of Duloxetine, aiding in the development of safer and more effective therapeutics. -
Drug Impurity
Levofloxacin impurity 1, also known as Levofloxacin impurity G, is a known impurity related to the antibiotic Levofloxacin. This compound serves as a valuable reference standard for analytical testing and quality control in pharmaceutical research and development. Its characterization can assist in the assessment of the purity and stability of Levofloxacin and facilitate investigations into potential drug interactions and efficacy. -
Drug Impurity
Dehydro glycopyrrolate bromide is identified as an impurity associated with the synthesis of glycopyrrolate. As a chemical research reagent, it is primarily utilized for quality control and validation within pharmaceutical development. Analysis of this impurity aids in understanding the stability and purity of glycopyrrolate formulations, thereby supporting regulatory compliance and product safety assessments.
